TTNPTITAN PHARMACEUTICALS INC

Nasdaq titanpharm.com


$ 5.65 $ 0.03 (0.52 %)    

Monday, 09-Sep-2024 15:37:44 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 5.76
$ 5.84
$ 6.48 x 100
-- x --
$ 5.65 - $ 5.84
$ 4.24 - $ 14.80
45,843
na
5.27M
$ 0.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-15-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-25-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-01-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-15-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-13-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

PANW: 5% | Palo Alto Networks shares are trading higher following better-than-expected Q4 financial results, issued strong guid...

 titan-pharmaceuticals-enters-merger-and-contribution-and-share-exchange-agreement-regarding-a-business-combination-with-ke-sdn-bhd

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan") today announced that it has entered into a Merger and Contribution ...

 why-agenus-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of ...

 the-sire-group-ltd-says-expect-to-propose-to-titan-pharmaceuticals-inc-a-business-combination-with-ke-sdn-bhd

- SEC 13D/Amended Filing After giving effect to these changes in membership, as of April 2, 2024, four of the board's seven...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION